Michael Malfatti

2.2k total citations
55 papers, 1.6k citations indexed

About

Michael Malfatti is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michael Malfatti has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 24 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Michael Malfatti's work include Carcinogens and Genotoxicity Assessment (19 papers), DNA Repair Mechanisms (10 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Michael Malfatti is often cited by papers focused on Carcinogens and Genotoxicity Assessment (19 papers), DNA Repair Mechanisms (10 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Michael Malfatti collaborates with scholars based in United States, United Kingdom and Switzerland. Michael Malfatti's co-authors include James S. Felton, Kenneth W. Turteltaub, Mark G. Knize, Rebekah W. Wu, Kristen S. Kulp, Cynthia P. Salmon, Heather A. Enright, Karen H. Dingley, Victoria Lao and Nicholas P. Lang and has published in prestigious journals such as Nano Letters, PLoS ONE and Analytical Chemistry.

In The Last Decade

Michael Malfatti

54 papers receiving 1.5k citations

Peers

Michael Malfatti
Bernhard H. Monien Germany
Silvia Balbo United States
N. V. S. Ramakrishna India
Alan M. Jeffrey United States
Jiri Aubrecht United States
Joseph B. Guttenplan United States
Sharon K. Krueger United States
M. Matilde Marques Portugal
Jorge Gaspar Portugal
Linda S. Von Tungeln United States
Bernhard H. Monien Germany
Michael Malfatti
Citations per year, relative to Michael Malfatti Michael Malfatti (= 1×) peers Bernhard H. Monien

Countries citing papers authored by Michael Malfatti

Since Specialization
Citations

This map shows the geographic impact of Michael Malfatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Malfatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Malfatti more than expected).

Fields of papers citing papers by Michael Malfatti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Malfatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Malfatti. The network helps show where Michael Malfatti may publish in the future.

Co-authorship network of co-authors of Michael Malfatti

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Malfatti. A scholar is included among the top collaborators of Michael Malfatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Malfatti. Michael Malfatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malfatti, Michael, Heather A. Enright, Esther A. Ubick, et al.. (2024). Evaluation of Subetadex-α-methyl, a Polyanionic Cyclodextrin Scaffold, as a Medical Countermeasure against Fentanyl and Related Opioids. ACS Central Science. 10(12). 2200–2212. 1 indexed citations
2.
Valdez, Carlos A., Doris Lam, Victoria Lao, et al.. (2023). Improved chemical synthesis, identification and evaluation of prospective centrally active oxime antidotes for the treatment of nerve agent exposure. Tetrahedron. 144. 133598–133598. 1 indexed citations
3.
4.
Bennion, Brian J., Michael Malfatti, Nicholas A. Be, et al.. (2021). Development of a CNS-permeable reactivator for nerve agent exposure: an iterative, multi-disciplinary approach. Scientific Reports. 11(1). 15567–15567. 12 indexed citations
5.
Zimmermann, Maike, Tao Li, Thomas J. Semrad, et al.. (2020). Oxaliplatin–DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy. Molecular Cancer Therapeutics. 19(4). 1070–1079. 20 indexed citations
6.
Cai, Hong, Edwina N. Scott, Robert G. Britton, et al.. (2020). Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a “dietary-achievable” or “pharmacological” dose: what are the implications for anticancer activity?. American Journal of Clinical Nutrition. 113(5). 1115–1125. 13 indexed citations
7.
Malfatti, Michael, Bruce A. Buchholz, Heather A. Enright, et al.. (2019). Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science. Toxics. 7(2). 27–27. 7 indexed citations
8.
Hum, Nicholas R., Kelly A. Martin, Michael Malfatti, et al.. (2018). Tracking Tumor Colonization in Xenograft Mouse Models Using Accelerator Mass Spectrometry. Scientific Reports. 8(1). 15013–15013. 5 indexed citations
9.
Wang, Fuli, Hongyong Zhang, Ai-Hong Ma, et al.. (2017). COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Molecular Cancer Therapeutics. 17(2). 474–483. 32 indexed citations
10.
Enright, Heather A., Michael Malfatti, Victoria Lao, et al.. (2017). Maternal exposure to an environmentally relevant dose of triclocarban results in perinatal exposure and potential alterations in offspring development in the mouse model. PLoS ONE. 12(8). e0181996–e0181996. 23 indexed citations
11.
Zimmermann, Maike, Hongyong Zhang, Michael Malfatti, et al.. (2016). Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice. Molecular Cancer Therapeutics. 16(2). 376–387. 22 indexed citations
12.
Zhang, Hongyong, Maike Zimmermann, Bin Hu, et al.. (2016). Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer. PLoS ONE. 11(1). e0146256–e0146256. 13 indexed citations
13.
Zhang, Hongyong, Maike Zimmermann, Sisi Wang, et al.. (2016). Diagnostic Microdosing Approach to Study Gemcitabine Resistance. Chemical Research in Toxicology. 29(11). 1843–1848. 8 indexed citations
14.
Dingley, Karen H., Esther A. Ubick, John S. Vogel, et al.. (2014). DNA Isolation and Sample Preparation for Quantification of Adduct Levels by Accelerator Mass Spectrometry. Methods in molecular biology. 1105. 147–157. 5 indexed citations
15.
Felton, James S., Mark G. Knize, Rebekah W. Wu, et al.. (2006). Mutagenic potency of food-derived heterocyclic amines. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 616(1-2). 90–94. 76 indexed citations
16.
Malfatti, Michael, Esther A. Ubick, & James S. Felton. (2005). The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5- b ]pyridine in vivo. Carcinogenesis. 26(11). 2019–2028. 24 indexed citations
17.
Felton, James S., Mark G. Knize, L. Michelle Bennett, et al.. (2004). Impact of environmental exposures on the mutagenicity/carcinogenicity of heterocyclic amines. Toxicology. 198(1-3). 135–145. 39 indexed citations
18.
Malfatti, Michael & James S. Felton. (2001). N-Glucuronidation of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) and N-hydroxy-PhIP by specific human UDP-glucuronosyltransferases. Carcinogenesis. 22(7). 1087–1093. 61 indexed citations
19.
Lang, Nicholas P., Susan Nowell, Michael Malfatti, et al.. (1999). In vivo human metabolism of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Cancer Letters. 143(2). 135–138. 21 indexed citations
20.
Malfatti, Michael, et al.. (1995). The metabolism and DNA binding of the cooked-food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in precision-cut rat liver slices. Chemico-Biological Interactions. 96(2). 185–202. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernhard H. Monien Breakdown of academic impact, for papers by Silvia Balbo Breakdown of academic impact, for papers by N. V. S. Ramakrishna Breakdown of academic impact, for papers by Alan M. Jeffrey Breakdown of academic impact, for papers by Jiri Aubrecht Breakdown of academic impact, for papers by Joseph B. Guttenplan Breakdown of academic impact, for papers by Sharon K. Krueger Breakdown of academic impact, for papers by M. Matilde Marques Breakdown of academic impact, for papers by Jorge Gaspar Breakdown of academic impact, for papers by Linda S. Von Tungeln
Rankless by CCL
2026